REBECCA TWEARDY: Open Payments
NPI 1144390907 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 9 payments from 8 companies in 2025. Trend: 2023 $625 · 2024 $147 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $46 |
| BETA BIONICS, INC. | 1 | $39 |
| Novo Nordisk Inc | 1 | $21 |
| Corcept Therapeutics | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Insulet Corporation | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: MINIMED 780G, iLet Bionic Pancreas, Ozempic, Korlym, Kerendia, Omnipod, CREXONT, REPATHA.
Industry payments across KY — which companies pay providers there.
